Navigation Links
Research Report on China's Antidepressant Market, 2013-2017
Date:6/12/2013

DUBLIN, June 12, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/b7j88d/research_report) has announced the addition of the "Research Report on China's Antidepressant Market, 2013-2017" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)


Oct. 10 is "World Mental Health Day". In 2012, its theme is "Depression: a Global Crisis". According to statistics from the United Nations, about 350 million people suffer from depression in the world. Approximately one million people commit suicide every year because of depression, thus depression becomes a health crisis worldwide.

In developed countries, the sales volume of medicines for depression and anxiety disorder amounts to 45% of market share of nervous centralis medicines. Depressant medicines and schizophrenia drugs totally account for 80% of world's mental disorder medicines. There are totally 50 to 60 varieties of antidepressants on the market or in development, which is more than therapeutic agents of schizophrenia. According to reports, the current eight best-selling antidepressants globally are Fluoxetine, Paroxetine, Sertraline, Fluvoxamine, Venlafaxine, Mirtazapine, Duloxetine and Amitriptyline, and the total sales amount exceeds 80% of global antidepressant market.

With the rapid development of economy, continuous improvement in people's living standards, continuously-intensified social competition, recombination of labour forces and changes in population and family structures, depression presents an obviously increasing trend in China. It is estimated that there are over 30 million depression patients in China, among which more than 90% cannot be promptly diagnosed and treated, causing deterioration of diseases and even serious consequences of committing suicide. Statistics show that committing suicide becomes an important cause of death among young adults aged between 15 and 34 in China. Among these crowds, depression patients account for about two-thirds.

At present, the market size of China's antidepressants is very small. In 2012, the market size of China's antidepressants in hospital medicines is only about CNY 3.2 billion, with an increase of 22.6% YOY. In terms of national medicine market, the antidepressant market is still in a small size on the whole. However, with the increasing recognition rate of doctors for depression and people's changes in treatment concepts, it is expected that the future potential of China's antidepressant market is fairly great. It is predicted that in the coming years, the annual growth rate of market size of China's antidepressants in hospital medicines will maintain over 20%.

The following information can be acquired through this report:

- Morbidity of China's Depression
- Current Market of China's Antidepressants in Hospital Medicines
- Competition in China's Antidepressant Market
- Development Trends of Technologies and Market of China's Antidepressants

People working in the industries listed below are recommended to buy this report:

- Antidepressant Manufacturers
- Pharmaceutical Trade Enterprises and Hospitals
- Investors and Research Institutions Focusing on Pharmaceutical Industry

Key Topics Covered:

1 Overview on Antidepressants

2 Market Conditions of China's Antidepressants, 2011-2012

3 Analysis on Major Varieties of China's Antidepressants, 2011-2012

4 Reference Prices of China's Major Antidepressants, 2012

5 Prediction on Development of China's Antidepressants, 2013-2017

For more information visit http:/http://www.researchandmarkets.com/research/b7j88d/research_report

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Pharmaceuticals



'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Research Report on Chinas Anti-Prostatic Hyperplasia (PH) Drug Market, 2013-2017
2. UC Irvine researchers unveil AsterixDB for Big Data management
3. Spanish researchers writing in cell describe the 9 hallmarks of aging
4. Biotech Services Take Advantage of Technological Revolution through Innovations - Research Report on Life Technologies, PerkinElmer, PAREXEL, Genomic Health, and Bio-Reference
5. EFIC-Grünenthal-Grant Awards Seven Innovative Research Projects
6. Designing the Future: Top Architects Answer the Call of North Carolina’s Research Triangle Park
7. NASA Selects 31 Space Biology Research Proposals
8. Health Diagnostic Laboratory, Inc.s new Diabetes Prevention & Management Panel incorporates discovery from Metabolon researchers
9. Singer-Songwriter Edwin McCain to Headline Steadman Philippon Research Institute's 2013 Annual "Rock the Research" Fundraiser in Vail, Colorado
10. The Sidney Kimmel Foundation for Cancer Research Announces 2013 Grant Recipients
11. Recent Research Questions the Effectiveness of Back Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... CA (PRWEB) , ... October 11, 2017 , ... ... upregulate any gene in its endogenous context, enabling overexpression experiments and avoiding the ... system with small RNA guides is transformative for performing systematic gain-of-function studies. ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017  SkylineDx ... London (ICR) and University of Leeds ... to risk-stratify patients with multiple myeloma (MM), in a multi-centric ... The University of Leeds is the ... UK, and ICR will perform the testing services to include ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... CALIFORNIA (PRWEB) , ... October 10, 2017 , ... ... technological innovation and business process optimization firm for the life sciences and healthcare ... BoxWorks conference in San Francisco. , The presentation, “Automating GxP Validation for ...
Breaking Biology Technology:
(Date:10/4/2017)... Oct. 4, 2017  GCE Solutions, a global clinical research organization ... document anonymization solution on October 4, 2017. Shadow is designed to ... comply with policy 0070 of the European Medicines Agency (EMA) in ... ... ...
(Date:8/15/2017)... , Aug. 15 2017   ivWatch LLC , a medical ... (IV) therapy, today announced receipt of its ISO 13485 Certification, the ... the International Organization for Standardization (ISO®). ... ivWatch Model 400 Continuous Monitoring device for the early detection ... "This is an important ...
(Date:6/30/2017)... 2017 Today, American Trucking Associations announced ... face and eye tracking software, became the newest ... "Artificial intelligence and advanced sensing ... a driver,s attentiveness levels while on the road.  ... detect fatigue and prevent potential accidents, which could ...
Breaking Biology News(10 mins):